Tamoxifen (tam, Figure 1), which is used worldwide for the treatment of breast cancer, competes with female hormone 17α-estradiol (E2) for binding to estrogen receptor α (ERα) [1]. The gene discussed is ESR1; the disease is breast carcinoma.